Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ami P. Vaidya"'
Publikováno v:
Gynecologic Oncology. 103:684-687
Objective Uterine mixed malignant mullerian tumors (MMMT) have traditionally been excluded from clinical trials of endometrial cancer because of a belief that they are more correctly included in the sarcoma category. Recently, investigators have sugg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d411b5dd21b7cc6a44afd6c24a65b33
https://doi.org/10.1016/j.ygyno.2006.05.009
https://doi.org/10.1016/j.ygyno.2006.05.009
Autor:
Jennifer Mahoney, Constanze Hampel, Debra A. Bell, Zhenfeng Duan, Hang Lee, Kathryn Wolak, Ami P. Vaidya, Rosemary Foster, Michael V. Seiden
Publikováno v:
Clinical Cancer Research. 12:5055-5063
Purpose: One of the major obstacles in the treatment of ovarian cancer is the development of multidrug resistance. Recent evidence shows that high-grade ovarian cancer often shows activation of the signal transducers and activators of transcription 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39e7d5bb3060423c8722f8d5c1ca33e
https://doi.org/10.1158/1078-0432.ccr-06-0861
https://doi.org/10.1158/1078-0432.ccr-06-0861
Autor:
Richard D. Kennedy, Michael V. Seiden, Anne Renee Hartman, Ami P. Vaidya, Deborah Chirnomas, Rosemary Foster, Michelle de la Vega, Toshiyasu Taniguchi, Alan D. D'Andrea, Maria Vasserman, Jennifer Mahoney
Publikováno v:
Molecular Cancer Therapeutics. 5:952-961
Cisplatin resistance occurs, at least in part, through the function of the Fanconi anemia (FA)/BRCA pathway, a DNA-damage response pathway required for repair of cisplatin cross-links. In the current study, we designed a cell-based screening strategy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5616fb5e335cab3e386aaaabd7440e7b
https://doi.org/10.1158/1535-7163.mct-05-0493
https://doi.org/10.1158/1535-7163.mct-05-0493
Publikováno v:
Current Treatment Options in Oncology. 6:103-114
The family of epidermal growth factor receptors (EGFRs) is overexpressed in many gynecologic malignancies. Extensive preclinical studies of these receptors demonstrate that they play an important role in supporting the growth of a wide variety of mal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec04c506ddc9b1f56f7904ef6851c03b
https://doi.org/10.1007/s11864-005-0018-x
https://doi.org/10.1007/s11864-005-0018-x
Autor:
Dennis S. Chi, Ennapadam Venkatraman, Carol Aghajanian, Richard R. Barakat, Ami P. Vaidya, Bhavana Pothuri
Publikováno v:
Gynecologic Oncology. 89:306-313
Objective Intestinal obstruction is a frequent sequela of recurrent ovarian cancer. Previous series report median survivals of 3–6 months in patients undergoing surgery for obstruction due to recurrent disease. We analyze a contemporary series of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5655f29d29029ad7ac356ba5bcb2742c
https://doi.org/10.1016/s0090-8258(03)00073-8
https://doi.org/10.1016/s0090-8258(03)00073-8
Publikováno v:
Gynecologic oncology. 103(1)
Background. Psammoma bodies in cervicovaginal cytology specimens are associated with malignant and benign conditions. Few studies have evaluated which features distinguish patients with underlying malignancy from those with benign conditions. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1149162d323cc5864cb39585360fe51
https://pubmed.ncbi.nlm.nih.gov/16624389
https://pubmed.ncbi.nlm.nih.gov/16624389